These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11422029)

  • 1. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells.
    Stoof TJ; Flier J; Sampat S; Nieboer C; Tensen CP; Boorsma DM
    Br J Dermatol; 2001 Jun; 144(6):1114-20. PubMed ID: 11422029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Watanabe S
    Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network.
    Ockenfels HM; Schultewolter T; Ockenfels G; Funk R; Goos M
    Br J Dermatol; 1998 Sep; 139(3):390-5. PubMed ID: 9767281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Shimizu T; Tada Y; Watanabe S
    Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antipsoriatic dimethyl-fumarate suppresses interferon-gamma -induced ICAM-1 and HLA-DR expression on hyperproliferative keratinocytes. Quantification by a culture plate-directed APAAP-ELISA technique.
    Sebok B; Bonnekoh B; Vetter R; Schneider I; Gollnick H; Mahrle G
    Eur J Dermatol; 1998; 8(1):29-32. PubMed ID: 9649687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease.
    Marshall A; Celentano A; Cirillo N; McCullough M; Porter S
    PLoS One; 2017; 12(3):e0172821. PubMed ID: 28253295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
    Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
    J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.
    Gasperini S; Marchi M; Calzetti F; Laudanna C; Vicentini L; Olsen H; Murphy M; Liao F; Farber J; Cassatella MA
    J Immunol; 1999 Apr; 162(8):4928-37. PubMed ID: 10202039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
    Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A
    J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine IP-10 expression in cultured human keratinocytes.
    Boorsma DM; Flier J; Sampat S; Ottevanger C; de Haan P; Hooft L; Willemze R; Tensen CP; Stoof TJ
    Arch Dermatol Res; 1998 Jun; 290(6):335-41. PubMed ID: 9705166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.
    Tahvili S; Zandieh B; Amirghofran Z
    Int J Dermatol; 2015 Jul; 54(7):e254-60. PubMed ID: 26108267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis.
    Proost P; Vynckier AK; Mahieu F; Put W; Grillet B; Struyf S; Wuyts A; Opdenakker G; Van Damme J
    Eur J Immunol; 2003 Nov; 33(11):3146-53. PubMed ID: 14579283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.
    Albanesi C; Scarponi C; Sebastiani S; Cavani A; Federici M; De Pità O; Puddu P; Girolomoni G
    J Immunol; 2000 Aug; 165(3):1395-402. PubMed ID: 10903743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.
    Gesser B; Johansen C; Rasmussen MK; Funding AT; Otkjaer K; Kjellerup RB; Kragballe K; Iversen L
    J Invest Dermatol; 2007 Sep; 127(9):2129-37. PubMed ID: 17495961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis.
    Brück J; Dringen R; Amasuno A; Pau-Charles I; Ghoreschi K
    Exp Dermatol; 2018 Jun; 27(6):611-624. PubMed ID: 29603404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT/enhancer binding protein beta in activated human T cells.
    Gerdes S; Shakery K; Mrowietz U
    Br J Dermatol; 2007 May; 156(5):838-42. PubMed ID: 17381463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.
    Gesser B; Rasmussen MK; Raaby L; Rosada C; Johansen C; Kjellerup RB; Kragballe K; Iversen L
    Inflamm Res; 2011 Jul; 60(7):643-53. PubMed ID: 21340650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
    Schafer PH; Parton A; Gandhi AK; Capone L; Adams M; Wu L; Bartlett JB; Loveland MA; Gilhar A; Cheung YF; Baillie GS; Houslay MD; Man HW; Muller GW; Stirling DI
    Br J Pharmacol; 2010 Feb; 159(4):842-55. PubMed ID: 20050849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethylfumarate inhibits CXCL10 via haem oxygenase-1 in airway smooth muscle.
    Seidel P; Hostettler KE; Hughes JM; Tamm M; Roth M
    Eur Respir J; 2013 Jan; 41(1):195-202. PubMed ID: 22790915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
    J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.